Achema middle east

Press Releases

AbbVie presents New, Late Breaking Investigational Data at 2018 at AAD Annual meeting

AbbVie  a global research and development-based biopharmaceutical company, today announced it will present new, late-breaking data across investigational medicines and HUMIRA® (adalimumab) at the 2018 American Academy of Dermatology (AAD) Annual Meeting (February 16-20, San Diego). ...

GSK’S Fluarix Tetra (Influenza Vaccine) for ages six months and older RECEIVES European Approval

GSK announced the expanded indication for Fluarix Tetra (Quadrivalent Influenza Vaccine) has been approved in Europe to include adults and now children from six months of age for the prevention of influenza disease caused by the two influenza A...

GSK submits landmark IMPACT data to European Medicines Agencies for supporting Trelegy Ellipta

GlaxoSmithKline plc and Innoviva, Inc. announced the submission of the landmark IMPACT data to the European Medicines Agency as part of a type II variation to support an expanded label for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol, ‘FF/UMEC/VI’) in Europe for...

FDA Approves Symdeko

Vertex Pharmaceuticals Incorporated announced that the U.S. FDA approved Symdeko (tezacaftor/ivacaftor and ivacaftor) for treating the underlying cause of cystic fibrosis (CF) in people ages 12 and older who have two copies of the F508del mutation in the cystic...

FDA Approves Erleada

The U.S. FDA approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment...

CRF Health’s ‘Outstanding Innovation’ with Pioneering TrialConsent® Wins 2018 Clinical Informatics News Best Practices Awards

CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, announced that its electronic informed consent solution, TrialConsent®, has won the 2018 Best Practices Award at this year’s Clinical Informatics News...

TraceLink Achieves 97% Revenue Growth in Q4 and 85% Overall Revenue Growth for 2017

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced financial and company results for the fourth quarter and  full year of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »